To evaluate the nucleotide sequence of the ß-exons, the amplified DNA, after an additional step of asymmetric amplification, were directly sequenced [2] using 5'-32P-labelled primers and a dideoxy-sequencing kit (USB, Denver, Colo., USA). The oligonucleotide primers used for sequencing fragment A were 5'.TGCTTCTGACACAACTGTG.3' (nt -45 to -27) and 5'.CCCTTCCTATGACATGAAC.3' (nt 71 to 53 in intron 2). Sequencing primer for fragment B was 5'.TCTGAGTCCAACGTAGGC.3' (nt 777 to 795 in intron 2). Fig. 2 . Nucleotide sequence of the 1st exon of the ß-globin gene. The contemporary presence of the normal (adenine) and the mutated (cytosine) nucleotide at position 2 of the 3rd codon is shown by the arrow. Sequencing analysis showed the contemporary presence of C and A nucleotides at position 2 of the third codon of the ß-globin gene, indicating a heterozygous state for that gene. In fact, one allele presented the normal 'CAC codon, encoding histidine, while in the other allele the codon was 'CCC which encodes proline and is specific for the rare 'Long Island-Marseille' Hb variant. No more abnormalities were seen in the rest of the ß-gene. Hemoglobin Long Island-Marseille is a ß-chain variant having an extended N-terminus, due to the lack of amino-terminal methionine cleavage, an alteration possibly caused by the inhibition of the methionine aminopepti-dase which removes the methionyl residue from growing peptides. The inhibition of this enzyme seems to be due to the histidine-to-proline substitution at the second amino acid position of the ß-chain [3, 4] , produced by the above-described point mutation in the first exon of the ß-gene. Only three carriers of this hemoglobin variant have been identified so far; none of them of Italian origin [3] [4] [5] . In the previous studies, the hemoglobin defect had been detected through amino acid analysis of the ß-chain, while the genomic alteration was also revealed by the sequencing of the reverse transcribed reticulocyte ß-globin mRNA in only one of them [6] . In the present study, we have confirmed this molecular defect through the direct examination of the ß-globin gene. This paper is the first report concerning the detection of the hemoglobin Long Island-Marseille in subjects of Italian origin. This hemoglobin variant coelutes with the HbAl fraction c, which consequently presents a falsely elevated level on HPLC analysis. For this reason, this variant was found only in 3 diabetic patients so far, as a result of routine clinical measurements of the glycated hemoglobin. Therefore, the real prevalence of this hemoglobin has not yet been estimated in the general population. Considering that we have found it only in 1 of the 1,250 blood donors examined, we may assume that Long Island-Marseille Hb variant has a low prevalence, at least in the Sicilian population.
